GWM
CNMD icon

Gilpin Wealth Management’s CONMED CNMD Stock Holding History

Gilpin Wealth Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$47 Sell
1
-4
-80% -$183 ﹤0.01% 1393
2026
Q2 		$164 Sell
5
-10
-67% -$360 ﹤0.01% 957
2026
Q1 		$531 Buy
+15
New +$610 ﹤0.01% 594

Other funds holding CNMD

CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
EP
EPIQ Partners Minneapolis, Minnesota $232M AUM 9.01% 1-Year Est. Return
FAM
Fenimore Asset Management Cobleskill, New York $4.55B AUM 5.53% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
DCM
Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

Gilpin Wealth Management's CNMD Position: Q3 2026 in Review

Gilpin Wealth Management reduced its CONMED (CNMD) stake by 80% in Q3 2026, selling an estimated $183 and leaving 1 share worth $47. The position accounts for ﹤0.01% of the portfolio, ranked #1393.

Gilpin Wealth Management first reported a position in CNMD in Q1 2026 and has held it in 3 quarters since. The position peaked at $531 in Q1 2026. 11 funds tracked by Wall St. Rank hold CNMD as of Q3 2026.

  • Gilpin Wealth Management held 1 share of CONMED worth $47 as of Q3 2026.
  • Gilpin Wealth Management sold 4 CONMED shares in Q3 2026, an estimated $183.
  • CONMED made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q3 2026, its #1393 holding.
  • Gilpin Wealth Management first reported a position in CONMED in Q1 2026 and has held it in 3 quarters since.
  • Gilpin Wealth Management's CONMED position peaked at $531 in Q1 2026.
  • 11 funds tracked by Wall St. Rank held CONMED as of Q3 2026.

Based on Gilpin Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.